What is flurona? Cases of co-infections increase amid peak Influenza season and Omicron variant surge

Smithsonian Magazine, Jan. 11, 2022

Opinion: Local pharmacies can reduce the dual risks of COVID19 and influenza this fall

The Hill,  Sept. 5, 2020 (Opinion)

UCI study points to new means of overcoming antiviral resistance in influenza

UC Irvine researchers have found a new approach to the creation of customized therapies for virulent flu strains that resist current antiviral drugs.

Woman in front of building looking at camera.

UCI shows education strategy increases patients’ willingness to get vaccinated

Emergency Department offers unique opportunity for general public outreach

Pharmaceutical Sciences professor John Chaput holds a vial of synthetic DNA

X Marks the Spot

Three questions with professor of pharmaceutical sciences John Chaput, who discusses using synthetic genetics in drug discovery

UCI awarded $13.8 million federal contract to profile lipid nanoparticles

Findings will increase understanding of vaccine immune responses and side effects

John Chaput

UCI-developed COVID-19 test detects, identifies specific variants with 100% accuracy

RNA-based method advances personalized medicine for improved patient care

2 new wildly contagious variants keeping Southern California COVID cases high

The Orange County Register, July 7, 2022

The COVID-19 pandemic is not over. How will we know when it is?

PolitiFact, Jan. 13, 2022

The future of COVID-19 is likely to mirror the flu, expert says

KCBS Radio, Dec. 9, 2021 (Audio)